Controlling West Nile virus using treated bird feed
West Nile virus control through mosquitocidal avian bloodmeals
This study is looking at a new way to help control the spread of West Nile virus by using special bird feeders that let birds take medicine to fight off mosquitoes, which can help keep people safe from the virus in neighborhoods and parks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-10906294 on NIH RePORTER |
What this research studies
This research investigates a novel approach to control West Nile virus (WNV) transmission by using bird feed treated with endectocides. The goal is to create feeding stations that allow birds to self-medicate, thereby reducing the population of mosquitoes that feed on them. By placing these stations in residential areas and parks, the project aims to lower the risk of WNV transmission to humans in regions most affected by the virus. The methodology involves testing the effectiveness of this approach in real-world settings to ensure safety and efficacy.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include residents in areas with high rates of West Nile virus transmission, particularly in the western United States.
Not a fit: Patients living in regions where West Nile virus is not prevalent may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of West Nile virus infections in humans and animals.
How similar studies have performed: While the approach of using treated bird feed is innovative, similar vector-targeted interventions have shown promise in controlling other mosquito-borne diseases.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Foy, Brian David — Colorado State University
- Study coordinator: Foy, Brian David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.